EP Patent

EP2607362B1 — Piperidine and piperazine carboxylates as FAAH inhibitors

Assigned to Astellas Pharma Inc · Expires 2014-12-31 · 11y expired

What this patent protects

Patent listed against avatrombopag-maleate.

Drugs covered by this patent

avatrombopag-maleate (AVATROMBOPAG MALEATE)

Patent Metadata

Patent number: EP2607362B1
Jurisdiction: EP
Classification: —
Expires: 2014-12-31
Drug substance claim: No
Drug product claim: No
Assignee: Astellas Pharma Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.